#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma Choroid melanoma Systemic candida Usher's syndrome Erythema multiforme Angiosarcoma recurrent Chronic cutaneous lupus erythematosus Acute myeloid leukaemia refractory Mastocytosis Autoimmune demyelinating disease Cholangiosarcoma T-cell lymphoma Arrhythmia Guillain-Barre syndrome Microscopic polyangiitis More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Diagnostics Alternating hemiplegia of childhood – Trials in Disease Pemphigoid – Diagnostics Behcet’s syndrome – Trials in Disease Skin angiosarcoma – Treatment Piriformis syndrome Factor VIII deficiency – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Waldenstrom’s macroglobulinaemia refractory – Basic Information Arterial tortuosity syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk3915393 GS-1720 Ly3556050 Povidone Alanyl Glutamine Casirivimab Sasanlimab ULVIPRUBART Posenacaftor Englumafusp Alfa LY4170156 Histidine Dexlansoprazole Sar442970 Mirabegron Mbf-118 GSK5733584 ACARBOSE Xanthum Gum Ruxolitinib More therapies…

    Learn about Your Condition

    Tardive dyskinesia Mixed dementia Venous thrombosis Alcohol use disorder Hepatic fibrosis Colorectal cancer metastatic Atrial fibrillation Primary hyperthyroidism Rectal cancer recurrent Anal fistula Hypoalbuminaemia Anal squamous cell carcinoma Malignant glioma Plasmablastic lymphoma Drug use disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Influenza

  • Study on Immune Responses to Influenza Vaccines in Health Care Workers Using Polysorbate 80, Sodium Citrate, and Citric Acid Anhydrous

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial infection
    • Viral infection
    • Influenza
    Investigated Drugs:
    • A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)
    • A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223)
    • CITRIC ACID ANHYDROUS
    Finland

  • Study of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cx-037231
    • Cx-039776
    • Cx-044933
    Belgium Bulgaria Estonia Finland Germany

  • Study of intravenous zanamivir safety and effectiveness in infants under 6 months of age with complicated influenza infection

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Zanamivir
    Italy Spain

  • Study on Aspirin and Pantoprazole for Reducing Heart Attack Risk in Hospitalized Pneumonia Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Pantoprazole
    • Acetylsalicylic Acid
    • Placebo
    The Netherlands

  • Live Attenuated Influenza Vaccine (LAIV) and Immune Response in the Nasopharynx of Young Children with Influenza

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • INFLUENZA VIRUS B/AUSTRIA/1359417/2021 – LIKE STRAIN (B/AUSTRIA/1359417/2021, MEDI 355292)
    The Netherlands

  • Study on the Effectiveness and Safety of CR9114 for Preventing Influenza in Healthy Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • WILD-TYPE A INFLUENZA VIRUS A/BELGIUM/4217/2015 (H3N2)
    Belgium
Previous Page
1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!